An estimated 40% of the patients have Parkinson’s disease psychosis, (PDP) a debilitating condition that is characterized by hallucinations and delusions, is associated with significant caregiver burden, and is a major reason for nursing home placement among Parkinson’s patients. Pimavanserin offers a viable treatment option for patients suffering from PDP. This article provides a basic information about pimavanserin used for treating hallucinations associated with Parkinson’s disease psychosis.
The motor symptoms of Parkinson’s disease (PD) are directly related to the progressive degeneration of primarily brain dopamine (DA) neurons. The motor symptoms of PD which were used to be the focus of treatment, now it is realized that non-motor symptoms are equally disturbing to the patient. Parkinson’s disease psychosis (PDP) is characterized by hallucinations and/or delusions, may develop in…
